ScanSource, Inc. filings document the reporting obligations of a Nasdaq-listed technology distributor with common stock traded under SCSC. Recent Form 8-K disclosures cover quarterly and fiscal-year operating results, earnings exhibits, Regulation FD materials, executive appointments, board leadership updates and changes in the company’s independent registered public accounting firm.
The company’s proxy materials provide governance and shareholder-meeting disclosures, while periodic reporting referenced in its earnings filings frames results against annual and quarterly reports. These records center on operating performance, financial presentation, corporate governance, auditor oversight and the capital-market status of ScanSource common stock.
SCANSOURCE, INC. (SCSC) received a notice that officer Michael L. Baur plans to sell restricted securities under Rule 144. The planned transaction covers 19,980 shares of common stock, arising from the exercise of employee stock options, through a broker assisted cashless sale dated September 10, 2026.
The filing lists an aggregate market value of $1,109,823.29 for these shares and shows 20,142,812 shares outstanding as of September 10, 2026. This amendment resubmits a prior notice with an updated number of outstanding shares.
SCANSOURCE, INC. (SCSC) received a notice of proposed sale of common stock under Rule 144 by officer Michael L. Baur. The notice covers the potential sale of 57,359 shares of common stock on NASDAQ on September 11, 2026, following the exercise of employee stock options. The filing lists 20,142,812 shares of common stock outstanding and notes that this is a resubmission of a prior September 11, 2026 notice to update the outstanding share count. It also reports that Baur sold 19,980 shares during the prior three months.
SCANSOURCE, INC. (SCSC) director Charles Alexander Mathis reported selling 3,000 shares of Common Stock on September 11, 2026 in an open market or private transaction at $58.00 per share. Following this sale, he directly holds 25,027 shares of ScanSource common stock. No Rule 10b5-1 trading plan is reported for this transaction.
SCANSOURCE, INC. (SCSC) reported that Chief Executive Officer, President and Board Chair Michael L. Baur exercised vested employee stock options and sold the resulting shares. On September 10 and 11, 2026, he exercised options for a total of 77,339 shares of common stock at an exercise price of $37.00 per share and acquired the same number of shares.
On those same dates he sold an aggregate of 77,339 shares of common stock in open-market transactions at weighted average prices in the mid‑$50s per share, with the reported price ranges from about $55.07 to $58.61 depending on the trade group. No Rule 10b5-1 trading plan is reported for these transactions, and the filing does not state his resulting share ownership.
SCANSOURCE, INC. (SCSC) received a Rule 144 notice from Michael Baur covering proposed sales of its common stock. The filing lists 57,359 shares of common stock to be sold through Merrill Lynch, with an aggregate market value of $3,328,776.77 and outstanding shares of 21,142,812 as of September 11, 2026.
The shares are to be sold in connection with the exercise of employee stock options, using a broker assisted cashless sale on September 11, 2026. The notice also reports that Baur sold 19,980 shares of common stock for $1,109,823.29 on September 10, 2026.
SCANSOURCE, INC. (SCSC) received a notice that officer Charles Mathis intends to sell 3,000 shares of Common Stock under Rule 144. The shares have an aggregate market value of $174,000 and are expected to be sold through Merrill Lynch on NASDAQ on or after September 11, 2026.
The shares derive from vested restricted stock unit awards, including 1,700 shares that vested on February 27, 2022 and 1,300 shares that vested on August 26, 2023, granted as part of the issuer’s equity compensation plan.
SCANSOURCE, INC. (SCSC) received a notice that Michael L. Baur intends to sell common stock under Rule 144. The planned sale covers 19,980 shares of common stock, with an aggregate market value of $1,109,823.29, based on outstanding shares of 21,142,812 as of the notice.
The shares are tied to an exercise of employee stock options and are expected to be sold around September 10, 2026 through a broker assisted cashless sale via Merrill Lynch on NASDAQ.
SCANSOURCE, INC. (SCSC) officer Brandy Ford, SVP & Chief Accounting Officer, reported selling a total of 5,293 shares of common stock on September 4, 2026 in two open-market or private transactions. The sales were executed at weighted average prices of $57.43 and $58.04, with detailed price ranges disclosed in footnotes. No Rule 10b5-1 trading plan is reported.
SCANSOURCE, INC. (SCSC) received a notice under Rule 144 that officer Brandy Ford may sell common stock through Merrill Lynch. The notice lists a proposed transaction involving ScanSource common stock on or after September 4, 2026, with a reported quantity of 5,293 and a reported value of 303,986.62.
The securities referenced arise from multiple vesting events of restricted stock unit awards granted under the issuer’s equity compensation plan, with vesting dates in August and September of 2025 and 2026 and individual vesting amounts ranging from 258 to 1,050 units.
SCANSOURCE, INC. (SCSC) reported that director Charles Alexander Mathis acquired 3,234 shares of common stock on September 1, 2026 through a grant, award, or other acquisition at a reported price of $0.00 per share, reflecting non-cash equity compensation. Following this award, he directly holds 28,027 shares of ScanSource common stock. No Rule 10b5-1 trading plan is reported for this transaction.